Search results for

testicular

Search within

Tools Blog Posts News Articles Pages

Showing 1–25 of 31 results

Cat. # Tool Name Tool Category
152689 Anti-PLAP [H17E2] Antibodies Key Info View Tool
151106 Anti-PLAP [HD 11F7] Antibodies Key Info View Tool
151107 Anti-PLAP [HD 8B6] Antibodies Key Info View Tool
151885 Anti-Alkaline phosphatase [AP1B9] Antibodies Key Info View Tool
158039 Anti-SPATA43 [Z79 P1C3*E1] Antibodies Key Info View Tool
160671 Anti-DJ-1 [E2-1A] Antibodies Key Info View Tool
151336 Anti-Alkaline phosphatase [AP-7/6/7] Antibodies Key Info View Tool
151071 Anti-Alkaline phosphatase [AAP1] Antibodies Key Info View Tool
153472 Anti-ACE (somatic isoform-2) [L10P4F3*F9] Antibodies Key Info View Tool
152690 Anti-CD13 [22A5] mAb Antibodies Key Info View Tool
151180 Anti-CyclinB1 [V92.1] Antibodies Key Info View Tool
151015 Anti-CyclinA [E70.1] Antibodies Key Info View Tool
151016 Anti-CyclinA [E72.1] Antibodies Key Info View Tool
151017 Anti-MBP [R29.6] Antibodies Key Info View Tool
151058 Anti-XPA [5A2] Antibodies Key Info View Tool
151059 Anti-RuvC [RuvC 5G9/3] mAb Antibodies Key Info View Tool
151088 Anti-CyclinA [E23.1] Antibodies Key Info View Tool
151089 Anti-CyclinA [E43.2] Antibodies Key Info View Tool
151090 Anti-EGFR [EGFR1] Antibodies Key Info View Tool
151156 Anti-Rb1 [Rb1 (1F8)] Antibodies Key Info View Tool
151157 Anti-ErbB3 [RTJ1] Antibodies Key Info View Tool
151183 Anti-CyclinA1 [XLA1-1] Antibodies Key Info View Tool
151184 Anti-CyclinA1 [XLA1-3] Antibodies Key Info View Tool
151261 Anti-CyclinA [AT10.2] Antibodies Key Info View Tool
151270 Anti-SCP3 [Cor 10G11/7] Antibodies Key Info View Tool

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.